Lawrence D. Wise

2.9k total citations
85 papers, 2.4k citations indexed

About

Lawrence D. Wise is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lawrence D. Wise has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 41 papers in Organic Chemistry and 38 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lawrence D. Wise's work include Receptor Mechanisms and Signaling (30 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuroscience and Neuropharmacology Research (18 papers). Lawrence D. Wise is often cited by papers focused on Receptor Mechanisms and Signaling (30 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuroscience and Neuropharmacology Research (18 papers). Lawrence D. Wise collaborates with scholars based in United States, Netherlands and United Kingdom. Lawrence D. Wise's co-authors include Thomas G. Heffner, Thomas A. Pugsley, Leonard T. Meltzer, David J. Wustrow, Hyacinth C. Akunne, Juan C. Jaén, Suzanne R. Kesten, Robert G. MacKenzie, Bradley W. Caprathe and Durk Dijkstra and has published in prestigious journals such as Journal of the American Chemical Society, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Lawrence D. Wise

85 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence D. Wise United States	27	1.4k	993	741	234	116	85	2.4k
Roger D. Norcross Switzerland	21	1.5k 1.0×	1.1k 1.1×	907 1.2×	258 1.1×	110 0.9×	33	2.8k
Janusz J. Kulagowski United Kingdom	29	806 0.6×	1.2k 1.2×	1.1k 1.5×	160 0.7×	98 0.8×	55	2.3k
Ian T. Forbes United Kingdom	26	663 0.5×	1.3k 1.3×	1.3k 1.8×	195 0.8×	147 1.3×	59	2.6k
James C. Barrow United States	29	823 0.6×	1.2k 1.2×	429 0.6×	302 1.3×	120 1.0×	68	2.4k
Mojgan Aghazadeh Tabrizi Italy	37	1.9k 1.4×	1.8k 1.8×	469 0.6×	430 1.8×	291 2.5×	104	4.0k
Robert W. Carling United States	27	1.0k 0.7×	889 0.9×	745 1.0×	223 1.0×	55 0.5×	66	2.3k
Pascal George France	22	569 0.4×	645 0.6×	487 0.7×	122 0.5×	90 0.8×	64	1.5k
J.S. Dileep Kumar United States	26	648 0.5×	586 0.6×	570 0.8×	348 1.5×	99 0.9×	99	2.0k
Michael R. Wood United States	28	797 0.6×	1.4k 1.4×	850 1.1×	263 1.1×	49 0.4×	79	2.4k
Angus M. MacLeod United Kingdom	27	893 0.6×	1.1k 1.1×	912 1.2×	100 0.4×	64 0.6×	62	2.4k

Countries citing papers authored by Lawrence D. Wise

Since Specialization

Citations

This map shows the geographic impact of Lawrence D. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence D. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence D. Wise more than expected).

Fields of papers citing papers by Lawrence D. Wise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence D. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence D. Wise. The network helps show where Lawrence D. Wise may publish in the future.

Co-authorship network of co-authors of Lawrence D. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence D. Wise. A scholar is included among the top collaborators of Lawrence D. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence D. Wise. Lawrence D. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belliotti, Thomas R., Thomas Capiris, Jack J. Kinsora, et al.. (2005). Structure−Activity Relationships of Pregabalin and Analogues That Target the α₂-δ Protein. Journal of Medicinal Chemistry. 48(7). 2294–2307. 173 indexed citations

Akunne, Hyacinth C., Kim Zoski, M. Duff Davis, et al.. (2000). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects. Neuropharmacology. 39(7). 1197–1210. 5 indexed citations

Rodenhuis, Nienke, Thomas A. Pugsley, Leonard T. Meltzer, et al.. (2000). Thiazoloindans and Thiazolobenzopyrans: A Novel Class of Orally Active Central Dopamine (Partial) Agonists. Journal of Medicinal Chemistry. 43(19). 3549–3557. 24 indexed citations

Yuen, Po‐wai, et al.. (2000). Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists: Benzimidazalone and Hydantoin as Phenol Replacements. Journal of Medicinal Chemistry. 43(9). 1892–1897. 24 indexed citations

Rodenhuis, Nienke, Durk Dijkstra, Håkan Wikström, et al.. (2000). Synthesis and Pharmacological Evaluation of Thiopyran Analogues of the Dopamine D₃ Receptor-Selective Agonist (4aR,10bR)-(+)-trans-3,4,4a,10b- Tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907). Journal of Medicinal Chemistry. 43(15). 2871–2882. 129 indexed citations

Wright, Jonathan L., Tracy F. Gregory, Suzanne R. Kesten, et al.. (2000). Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines. Journal of Medicinal Chemistry. 43(18). 3408–3419. 95 indexed citations

Gregory, Tracy F., Jon L. Wright, Lawrence D. Wise, et al.. (2000). Parallel synthesis of a series of subtype-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(6). 527–529. 8 indexed citations

Meltzer, Leonard T., Margaret I. Davis, Robert G. MacKenzie, et al.. (1996). Preclinical pharmacology of dopamine partial agonists. European Neuropsychopharmacology. 6. 18–18. 1 indexed citations

Akunne, Hyacinth C., Durk Dijkstra, Håkan Wikström, et al.. (1995). Characterization of binding of [3H]PD 128907, A selective Dopamine D3 receptor agonist ligand, to CHO-K1 cells. Life Sciences. 57(15). 1401–1410. 37 indexed citations

10.

Pugsley, Thomas A., Hyacinth C. Akunne, Steven Z. Whetzel, et al.. (1995). Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists. Peptides. 16(1). 37–44. 30 indexed citations

11.

Glase, Shelly A., A. Corbin, Thomas A. Pugsley, Thomas G. Heffner, & Lawrence D. Wise. (1995). Synthesis and dopaminergic activity of pyridine analogs of 5-hydroxy-2-(di-n-propylamino)tetralin. Journal of Medicinal Chemistry. 38(16). 3132–3137. 17 indexed citations

12.

Wright, Jon L., Dennis M. Downing, Roger N. Hayes, et al.. (1995). Identification, Characterization and Pharmacological Profile of Three Metabolites of (R)-(+)-1,2,3,6-Tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1-yl)methyl]p yridine (CI-1007), a Dopamine Autoreceptor Agonist and Potential Antipsychotic Agent. Journal of Medicinal Chemistry. 38(26). 5007–5014. 9 indexed citations

13.

Jaén, Juan C., Bradley W. Caprathe, Thomas A. Pugsley, Lawrence D. Wise, & Hyacinth C. Akunne. (1993). Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and .sigma. receptors. Journal of Medicinal Chemistry. 36(24). 3929–3936. 26 indexed citations

14.

Jaén, Juan C., et al.. (1991). Synthesis of the Enantiomers of Reduced Haloperidol. Pharmaceutical Research. 8(8). 1002–1005. 15 indexed citations

15.

Jaén, Juan C., Lawrence D. Wise, Thomas G. Heffner, Thomas A. Pugsley, & Leonard T. Meltzer. (1991). Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones. Journal of Medicinal Chemistry. 34(1). 248–256. 34 indexed citations

16.

Jaén, Juan C., Lawrence D. Wise, Bradley W. Caprathe, et al.. (1990). 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties. Journal of Medicinal Chemistry. 33(1). 311–317. 229 indexed citations

17.

Tecle, Haile, Stephen C. Bergmeier, Lawrence D. Wise, et al.. (1989). Alkyl substituted 3‐PPP derivatives. Synthesis and biological investigation. Journal of Heterocyclic Chemistry. 26(4). 1125–1128. 7 indexed citations

18.

Hershenson, Fred M., Lawrence D. Wise, David A. Downs, et al.. (1988). Synthesis and potential antipsychotic activity of 1H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidines. Journal of Medicinal Chemistry. 31(2). 454–461. 17 indexed citations

19.

Wise, Lawrence D., Donald E. Butler, Linda L. Coughenour, et al.. (1987). 1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agents. Journal of Medicinal Chemistry. 30(10). 1807–1812. 29 indexed citations

20.

Stein, Theodore A., et al.. (1977). Prevention of stress ulcerations with cimetidine and carbenoxolone.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28. 361–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact